The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance.

Pretorius MM, Gainer JV, Van Guilder GP, Coelho EB, Luther JM, Fong P, Rosenbaum DD, Malave HA, Yu C, Ritchie MD, Vaughan DE, Brown NJ
Clin Pharmacol Ther. 2008 83 (1): 122-9

PMID: 17522594 · DOI:10.1038/sj.clpt.6100250

We examined the effect of -58 C/T and BE1 +9/-9 polymorphisms in the bradykinin B2 receptor gene on forearm vascular resistance (FVR) before and during intrabrachial artery infusion of the B2 receptor-, endothelium-dependent agonist bradykinin and the endothelium-independent agonist sodium nitroprusside in 228 normotensive subjects. In 166 white Americans, systolic blood pressure (SBP) and pulse pressure were highest in the BE1 +9/+9 group (118+/-2 and 51+/-2 mm Hg, respectively; P<0.05 versus -9/-9 for either), intermediate in the +9/-9 group (114+/-1 and 49+/-1 mm Hg, P<0.05 versus -9/-9 for pulse pressure), and lowest in the -9/-9 group (110+/-2 and 44+/-2 mm Hg). In 62 black Americans, FVR was 25% higher in the BE1 +9/+9 group compared with the BE1 +9/-9 and -9/-9 groups at baseline (P=0.038) or during bradykinin (P=0.03). Increased SBP or vascular resistance may contribute to increased left ventricular mass reported previously in individuals with the BE1+9/+9 genotype.

MeSH Terms (21)

Adult African Americans Blood Flow Velocity Blood Pressure Bradykinin Dose-Response Relationship, Drug European Continental Ancestry Group Female Forearm Gene Frequency Genotype Humans Infusions, Intra-Arterial Male Nitroprusside Phenotype Polymorphism, Genetic Receptor, Bradykinin B2 Regional Blood Flow Vascular Resistance Vasodilator Agents

Connections (2)

This publication is referenced by other Labnodes entities: